Annual Revenue
$5.49 M
+$4.25 M+340.96%
31 December 2023
Summary:
Cue Biopharma annual revenue is currently $5.49 million, with the most recent change of +$4.25 million (+340.96%) on 31 December 2023. During the last 3 years, it has risen by +$2.34 million (+74.05%). CUE annual revenue is now -63.26% below its all-time high of $14.94 million, reached on 31 December 2021.CUE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$3.34 M
+$678.00 K+25.51%
30 September 2024
Summary:
Cue Biopharma quarterly revenue is currently $3.34 million, with the most recent change of +$678.00 thousand (+25.51%) on 30 September 2024. Over the past year, it has increased by +$1.24 million (+58.86%). CUE quarterly revenue is now -59.59% below its all-time high of $8.25 million, reached on 31 December 2021.CUE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$9.53 M
+$1.24 M+14.90%
30 September 2024
Summary:
Cue Biopharma TTM revenue is currently $9.53 million, with the most recent change of +$1.24 million (+14.90%) on 30 September 2024. Over the past year, it has increased by +$5.71 million (+149.53%). CUE TTM revenue is now -36.20% below its all-time high of $14.94 million, reached on 31 December 2021.CUE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +341.0% | +58.9% | +149.5% |
| 3 y3 years | +74.0% | +39.3% | +33.1% |
| 5 y5 years | +380.5% | +239.0% | +247.9% |
CUE Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -63.3% | +341.0% | -59.6% | >+9999.0% | -36.2% | +2106.5% |
| 5 y | 5 years | -63.3% | +380.5% | -59.6% | >+9999.0% | -36.2% | +2106.5% |
| alltime | all time | -63.3% | +380.5% | -59.6% | >+9999.0% | -36.2% | +5441.9% |
Cue Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.34 M(+25.5%) | $9.53 M(+14.9%) |
| June 2024 | - | $2.66 M(+54.8%) | $8.30 M(+18.2%) |
| Mar 2024 | - | $1.72 M(-5.7%) | $7.02 M(+27.9%) |
| Dec 2023 | $5.49 M(+341.0%) | $1.82 M(-13.3%) | $5.49 M(+43.7%) |
| Sept 2023 | - | $2.10 M(+52.0%) | $3.82 M(+113.6%) |
| June 2023 | - | $1.38 M(+639.0%) | $1.79 M(+313.9%) |
| Mar 2023 | - | $187.00 K(+23.8%) | $432.00 K(-65.3%) |
| Dec 2022 | $1.25 M(-91.7%) | $151.00 K(+122.1%) | $1.25 M(-86.7%) |
| Sept 2022 | - | $68.00 K(+161.5%) | $9.35 M(-19.9%) |
| June 2022 | - | $26.00 K(-97.4%) | $11.68 M(-18.9%) |
| Mar 2022 | - | $1.00 M(-87.9%) | $14.39 M(-3.7%) |
| Dec 2021 | $14.94 M | $8.25 M(+244.7%) | $14.94 M(+108.6%) |
| Sept 2021 | - | $2.40 M(-12.6%) | $7.16 M(+30.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $2.74 M(+76.4%) | $5.47 M(+43.7%) |
| Mar 2021 | - | $1.55 M(+226.7%) | $3.81 M(+20.7%) |
| Dec 2020 | $3.15 M(-8.8%) | $475.30 K(-32.5%) | $3.15 M(-15.4%) |
| Sept 2020 | - | $704.00 K(-34.5%) | $3.73 M(-7.0%) |
| June 2020 | - | $1.07 M(+19.4%) | $4.01 M(+0.5%) |
| Mar 2020 | - | $900.00 K(-14.2%) | $3.99 M(+15.3%) |
| Dec 2019 | $3.46 M(+202.7%) | $1.05 M(+6.6%) | $3.46 M(+26.2%) |
| Sept 2019 | - | $984.00 K(-6.7%) | $2.74 M(+24.3%) |
| June 2019 | - | $1.05 M(+185.1%) | $2.20 M(+66.8%) |
| Mar 2019 | - | $370.00 K(+11.9%) | $1.32 M(+38.9%) |
| Dec 2018 | $1.14 M | $330.60 K(-26.4%) | $951.60 K(+53.2%) |
| Sept 2018 | - | $449.00 K(+161.0%) | $621.00 K(+261.0%) |
| June 2018 | - | $172.00 K | $172.00 K |
FAQ
- What is Cue Biopharma annual revenue?
- What is the all time high annual revenue for Cue Biopharma?
- What is Cue Biopharma annual revenue year-on-year change?
- What is Cue Biopharma quarterly revenue?
- What is the all time high quarterly revenue for Cue Biopharma?
- What is Cue Biopharma quarterly revenue year-on-year change?
- What is Cue Biopharma TTM revenue?
- What is the all time high TTM revenue for Cue Biopharma?
- What is Cue Biopharma TTM revenue year-on-year change?
What is Cue Biopharma annual revenue?
The current annual revenue of CUE is $5.49 M
What is the all time high annual revenue for Cue Biopharma?
Cue Biopharma all-time high annual revenue is $14.94 M
What is Cue Biopharma annual revenue year-on-year change?
Over the past year, CUE annual revenue has changed by +$4.25 M (+340.96%)
What is Cue Biopharma quarterly revenue?
The current quarterly revenue of CUE is $3.34 M
What is the all time high quarterly revenue for Cue Biopharma?
Cue Biopharma all-time high quarterly revenue is $8.25 M
What is Cue Biopharma quarterly revenue year-on-year change?
Over the past year, CUE quarterly revenue has changed by +$1.24 M (+58.86%)
What is Cue Biopharma TTM revenue?
The current TTM revenue of CUE is $9.53 M
What is the all time high TTM revenue for Cue Biopharma?
Cue Biopharma all-time high TTM revenue is $14.94 M
What is Cue Biopharma TTM revenue year-on-year change?
Over the past year, CUE TTM revenue has changed by +$5.71 M (+149.53%)